vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $117.7M, roughly 1.9× Resolute Holdings Management, Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs -1.5%, a 20.8% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $34.8M).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

ORGO vs RHLD — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.9× larger
ORGO
$225.6M
$117.7M
RHLD
Higher net margin
ORGO
ORGO
20.8% more per $
ORGO
19.4%
-1.5%
RHLD
More free cash flow
RHLD
RHLD
$154.5M more FCF
RHLD
$189.2M
$34.8M
ORGO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ORGO
ORGO
RHLD
RHLD
Revenue
$225.6M
$117.7M
Net Profit
$43.7M
$-1.7M
Gross Margin
55.7%
Operating Margin
28.1%
30.2%
Net Margin
19.4%
-1.5%
Revenue YoY
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$0.31
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
RHLD
RHLD
Q4 25
$225.6M
$117.7M
Q3 25
$150.9M
$120.9M
Q2 25
$101.0M
$119.6M
Q1 25
$86.7M
$103.9M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$130.2M
Q1 24
$110.0M
Net Profit
ORGO
ORGO
RHLD
RHLD
Q4 25
$43.7M
$-1.7M
Q3 25
$21.6M
$-231.0K
Q2 25
$-9.4M
$-611.0K
Q1 25
$-18.8M
$-3.4M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$-17.0M
Q1 24
$-2.1M
Gross Margin
ORGO
ORGO
RHLD
RHLD
Q4 25
55.7%
Q3 25
59.0%
Q2 25
57.5%
Q1 25
72.6%
52.5%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
ORGO
ORGO
RHLD
RHLD
Q4 25
28.1%
30.2%
Q3 25
13.7%
34.3%
Q2 25
-12.5%
34.0%
Q1 25
-30.9%
24.7%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Q1 24
-3.5%
Net Margin
ORGO
ORGO
RHLD
RHLD
Q4 25
19.4%
-1.5%
Q3 25
14.3%
-0.2%
Q2 25
-9.3%
-0.5%
Q1 25
-21.7%
-3.2%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
-13.1%
Q1 24
-1.9%
EPS (diluted)
ORGO
ORGO
RHLD
RHLD
Q4 25
$0.31
$-0.20
Q3 25
$0.11
$-0.03
Q2 25
$-0.10
$-0.07
Q1 25
$-0.17
$-0.39
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.13
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$93.7M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$300.1M
$6.5M
Total Assets
$598.7M
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
RHLD
RHLD
Q4 25
$93.7M
$205.5M
Q3 25
$63.7M
$148.0M
Q2 25
$73.1M
$99.9M
Q1 25
$110.0M
$71.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Q1 24
$88.6M
Total Debt
ORGO
ORGO
RHLD
RHLD
Q4 25
$169.8M
Q3 25
$173.4M
Q2 25
$177.1M
Q1 25
$180.7M
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
ORGO
ORGO
RHLD
RHLD
Q4 25
$300.1M
$6.5M
Q3 25
$255.1M
$10.8M
Q2 25
$233.2M
$9.6M
Q1 25
$242.9M
$8.9M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$263.5M
Q1 24
$278.0M
Total Assets
ORGO
ORGO
RHLD
RHLD
Q4 25
$598.7M
$333.4M
Q3 25
$509.8M
$293.2M
Q2 25
$461.1M
$253.3M
Q1 25
$467.4M
$214.3M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$443.2M
Q1 24
$458.5M
Debt / Equity
ORGO
ORGO
RHLD
RHLD
Q4 25
26.03×
Q3 25
16.01×
Q2 25
18.42×
Q1 25
20.38×
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
RHLD
RHLD
Operating Cash FlowLast quarter
$39.4M
$196.1M
Free Cash FlowOCF − Capex
$34.8M
$189.2M
FCF MarginFCF / Revenue
15.4%
160.8%
Capex IntensityCapex / Revenue
2.1%
5.8%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
RHLD
RHLD
Q4 25
$39.4M
$196.1M
Q3 25
$3.1M
$59.6M
Q2 25
$-32.9M
$48.9M
Q1 25
$-19.9M
$18.4M
Q4 24
$10.9M
Q3 24
$8.7M
Q2 24
$4.7M
Q1 24
$-10.2M
Free Cash Flow
ORGO
ORGO
RHLD
RHLD
Q4 25
$34.8M
$189.2M
Q3 25
$844.0K
$58.6M
Q2 25
$-36.5M
$47.5M
Q1 25
$-23.6M
$17.8M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
Q1 24
$-12.4M
FCF Margin
ORGO
ORGO
RHLD
RHLD
Q4 25
15.4%
160.8%
Q3 25
0.6%
48.5%
Q2 25
-36.1%
39.7%
Q1 25
-27.2%
17.1%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Q1 24
-11.3%
Capex Intensity
ORGO
ORGO
RHLD
RHLD
Q4 25
2.1%
5.8%
Q3 25
1.5%
0.8%
Q2 25
3.6%
1.2%
Q1 25
4.2%
0.6%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Q1 24
2.0%
Cash Conversion
ORGO
ORGO
RHLD
RHLD
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons